Skip to content

Manipulation of Dietary Protein and the Anabolic Response

The Manipulation of Dietary Protein Intake on the Anabolic Response in Healthy Young Men

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01820975
Acronym
PRO-ADAPT
Enrollment
28
Registered
2013-03-29
Start date
2013-04-30
Completion date
2017-02-01
Last updated
2017-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Focus: Anabolic Response to Food Intake in Young Individuals, Condition Relevance: Skeletal Muscle Health, Sarcopenia

Keywords

Muscle protein synthesis, Dietary protein

Brief summary

In the present study, the effect of habitual dietary protein on the anabolic response will be investigated.

Interventions

DIETARY_SUPPLEMENTHigh protein intake
OTHERPlacebo comparator

No protein intake

Sponsors

Maastricht University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Males * Aged between 18-35 years * Healthy, recreationally active * BMI \< 30 kg/m2

Exclusion criteria

* Smoking * Allergies to milk proteins (whey or casein) * Vegetarians * Diagnosed GI tract diseases * Female * Arthritic conditions * A history of neuromuscular problems * Previous participation in amino acid tracer studies * Individuals on any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescription strength acne medications

Design outcomes

Primary

MeasureTime frameDescription
Muscle protein fractional synthetic rate following protein ingestion3 hoursThe ability of the muscle to synthesise new proteins will be assessed over a 3 h period following protein ingestion and will be compared between groups. This only occurs on one occasion.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026